The Tigris self-expanding stent for peripheral artery disease was granted approval by the FDA. It is cleared for patients with proximal aortic neck angles up to 90 degrees and those with a minimum aortic neck length of 10 mm.
The Permaseal transapical access and closure device has won FDA approval, less than 2 months after European clearance.
Boston Scientific issued a recall for its transcatheter aortic Lotus Valve, owing to issues with release mandrel breakage. There have been three reports of fatal vessel trauma associated with the defect.
Small gains ahead: The Centers of Medicare & Medicaid confirmed increases in payments for fiscal year 2017 for mitral valve repair, left atrial appendage closure, carotid stenting, pacemaker implantation, and transcatheter aortic valve replacement. Inpatient reimbursement across cardiology will rise by 2.7% overall.
An interventionalist in the driver's seat? A steerable catheter to treat cardiac arrhythmia has been developed by Cambridge Design Partnership and King's College London. The device turns, emits radiofrequency energy, and is compatible with robotic ablation.
Patients with isolated systolic hypertension saw a smaller reduction in systolic blood pressure after renal denervation compared with their peers with combined systolic-diastolic hypertension, a SYMPLICITY HTN-3 trial and registry analysis showed.
A dedicated bifurcation stent, the Axxess, was positioned inaccurately in 13% of patients, according to a registry study. Investigators suggested a link to calcification and distal lesion sites.
Under investigation: stress testing with an anti-gravity treadmill. The technique could expand stress testing to patients who have foot and walking problems.